Skip to main content
Top
Published in: Archives of Dermatological Research 4/2023

17-11-2022 | Folliculitis | Original Paper

Human leukocyte antigen system associations in Malassezia-related skin diseases

Authors: P. Lindsø Andersen, G. B. Jemec, C. Erikstrup, M. Didriksen, K. M. Dinh, S. Mikkelsen, E. Sørensen, K. R. Nielsen, M. T. Bruun, H. Hjalgrim, T. F. Hansen, S. G. Sækmose, S. R. Ostrowski, D. M. L. Saunte, O. B. Pedersen, DBDS Genetic Consortium

Published in: Archives of Dermatological Research | Issue 4/2023

Login to get access

Abstract

Background

The human leukocyte antigen system (HLA) is divided into two classes involved in antigen presentation: class I presenting intracellular antigens and class II presenting extracellular antigens. While susceptibility to infections is correlated with the HLA system, data on associations between HLA genotypes and Malassezia-related skin diseases (MRSD) are lacking. Thus, the objective of this study was to investigate associations between HLA alleles and MRSD.

Materials and methods

Participants in The Danish Blood Donor Study (2010–2018) provided questionnaire data on life style, anthropometric measures, and registry data on filled prescriptions. Genotyping was done using Illumina Infinium Global Screening Array, and HLA alleles were imputed using the HIBAG algorithm. Cases and controls were defined using filled prescriptions on topical ketoconazole 2% as a proxy of MRSD. Logistic regressions assessed associations between HLA alleles and MRSD adjusted for confounders and Bonferroni corrected for multiple tests.

Results

A total of 9455 participants were considered MRSD cases and 24,144 participants as controls. We identified four risk alleles B*57:01, OR 1.19 (95% CI: 1.09–1.31), C*01:02, OR 1.19 (95% CI: 1.08–1.32), C*06:02, OR 1.14 (95% CI: 1.08–1.22), and DRB1*01:01, OR 1.10 (95% CI: 1.04–1.17), and two protective alleles, DQB1*02:01, OR 0.89 (95% CI: 0.85–0.94), and DRB1*03:01, OR 0.89 (95% CI: 0.85–0.94).

Conclusion

Five novel associations between HLA alleles and MRSD were identified in our cohort, and one previous association was confirmed. Future studies should assess the correlation between Malassezia antigens and antigen-binding properties of the associated HLA alleles.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shiina T, Hosomichi K, Inoko H, Kulski JK (2009) The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54(1):15–39PubMedCrossRef Shiina T, Hosomichi K, Inoko H, Kulski JK (2009) The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54(1):15–39PubMedCrossRef
2.
3.
go back to reference Sparber F, De Gregorio C, Steckholzer S, Ferreira FM, Dolowschiak T, Ruchti F et al (2019) The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation. Cell Host Microbe 25(3):389-403.e6PubMedCrossRef Sparber F, De Gregorio C, Steckholzer S, Ferreira FM, Dolowschiak T, Ruchti F et al (2019) The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation. Cell Host Microbe 25(3):389-403.e6PubMedCrossRef
5.
go back to reference Hansen TF, Banasik K, Erikstrup C, Pedersen OB, Westergaard D, Chmura PJ et al (2019) DBDS Genomic Cohort, a prospective and comprehensive resource for integrative and temporal analysis of genetic, environmental and lifestyle factors affecting health of blood donors. BMJ Open 9(6):e028401PubMedPubMedCentralCrossRef Hansen TF, Banasik K, Erikstrup C, Pedersen OB, Westergaard D, Chmura PJ et al (2019) DBDS Genomic Cohort, a prospective and comprehensive resource for integrative and temporal analysis of genetic, environmental and lifestyle factors affecting health of blood donors. BMJ Open 9(6):e028401PubMedPubMedCentralCrossRef
6.
go back to reference The European Commission (2004) COMMISSION DIRECTIVE 2004/33/EC of 22 March 2004. In: T.E. Union (ed) Official Journal of the European Union The European Commission (2004) COMMISSION DIRECTIVE 2004/33/EC of 22 March 2004. In: T.E. Union (ed) Official Journal of the European Union
7.
go back to reference Lindso Andersen P, Jemec GBE, Loft IC, Saunte DML, Pedersen OB (2021) Quality of life in Danish blood donors treated for superficial fungal infections. Acta Derm Venereol 101(12):617CrossRef Lindso Andersen P, Jemec GBE, Loft IC, Saunte DML, Pedersen OB (2021) Quality of life in Danish blood donors treated for superficial fungal infections. Acta Derm Venereol 101(12):617CrossRef
8.
go back to reference Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR et al (2014) HIBAG–HLA genotype imputation with attribute bagging. Pharmacogenomics J 14(2):192–200PubMedCrossRef Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR et al (2014) HIBAG–HLA genotype imputation with attribute bagging. Pharmacogenomics J 14(2):192–200PubMedCrossRef
9.
go back to reference Abraham G, Qiu Y, Inouye M (2017) FlashPCA2: principal component analysis of Biobank-scale genotype datasets. Bioinformatics (Oxf Engl) 33(17):2776–2778CrossRef Abraham G, Qiu Y, Inouye M (2017) FlashPCA2: principal component analysis of Biobank-scale genotype datasets. Bioinformatics (Oxf Engl) 33(17):2776–2778CrossRef
10.
go back to reference Sampaio AL, Porto LC, Ramos-e-Silva M, Nunes AP, Cardoso-Oliveira J, Fabricio-Silva GM et al (2014) Human leucocyte antigen frequency in a miscegenated population presenting with seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 28(11):1576–1577PubMedCrossRef Sampaio AL, Porto LC, Ramos-e-Silva M, Nunes AP, Cardoso-Oliveira J, Fabricio-Silva GM et al (2014) Human leucocyte antigen frequency in a miscegenated population presenting with seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 28(11):1576–1577PubMedCrossRef
11.
go back to reference Langton DJ, Bourke SC, Lie BA, Reiff G, Natu S, Darlay R et al (2021) The influence of HLA genotype on the severity of COVID-19 infection. HLA 18:509 Langton DJ, Bourke SC, Lie BA, Reiff G, Natu S, Darlay R et al (2021) The influence of HLA genotype on the severity of COVID-19 infection. HLA 18:509
13.
go back to reference Weidinger S, Willis-Owen SA, Kamatani Y, Baurecht H, Morar N, Liang L et al (2013) A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet 22(23):4841–4856PubMedPubMedCentralCrossRef Weidinger S, Willis-Owen SA, Kamatani Y, Baurecht H, Morar N, Liang L et al (2013) A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet 22(23):4841–4856PubMedPubMedCentralCrossRef
14.
go back to reference Margolis DJ, Mitra N, Kim B, Gupta J, Hoffstad OJ, Papadopoulos M et al (2015) Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis. Hum Immunol 76(8):571–577PubMedPubMedCentralCrossRef Margolis DJ, Mitra N, Kim B, Gupta J, Hoffstad OJ, Papadopoulos M et al (2015) Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis. Hum Immunol 76(8):571–577PubMedPubMedCentralCrossRef
15.
go back to reference Kieffer M, Bergbrant IM, Faergemann J, Jemec GB, Ottevanger V, Skov PS et al (1990) Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 22(5):739–742PubMedCrossRef Kieffer M, Bergbrant IM, Faergemann J, Jemec GB, Ottevanger V, Skov PS et al (1990) Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 22(5):739–742PubMedCrossRef
17.
go back to reference C. Genetic Analysis of Psoriasis, C. the Wellcome Trust Case Control, Strange A, Capon F, Spencer CC, Knight J et al (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42(11):985–990CrossRef C. Genetic Analysis of Psoriasis, C. the Wellcome Trust Case Control, Strange A, Capon F, Spencer CC, Knight J et al (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42(11):985–990CrossRef
19.
go back to reference McGonagle D, Aydin SZ, Gul A, Mahr A, Direskeneli H (2015) ’MHC-I-opathy’-unified concept for spondyloarthritis and Behcet disease. Nat Rev Rheumatol 11(12):731–740PubMedCrossRef McGonagle D, Aydin SZ, Gul A, Mahr A, Direskeneli H (2015) ’MHC-I-opathy’-unified concept for spondyloarthritis and Behcet disease. Nat Rev Rheumatol 11(12):731–740PubMedCrossRef
20.
go back to reference Weitz JE, Ritchlin CT (2014) Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis. Expert Opin Biol Ther 14(4):515–526PubMedCrossRef Weitz JE, Ritchlin CT (2014) Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis. Expert Opin Biol Ther 14(4):515–526PubMedCrossRef
21.
go back to reference Wang WY, Tian W, Zhu FM, Liu XX, Li LX, Wang F (2016) MICA, MICB polymorphisms and linkage disequilibrium with HLA-B in a Chinese Mongolian population. Scand J Immunol 83(6):456–462PubMedCrossRef Wang WY, Tian W, Zhu FM, Liu XX, Li LX, Wang F (2016) MICA, MICB polymorphisms and linkage disequilibrium with HLA-B in a Chinese Mongolian population. Scand J Immunol 83(6):456–462PubMedCrossRef
22.
go back to reference Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, Cazaly A et al (2010) Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci USA 107(22):10160–10165PubMedPubMedCentralCrossRef Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, Cazaly A et al (2010) Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci USA 107(22):10160–10165PubMedPubMedCentralCrossRef
23.
go back to reference Nowicka D, Nawrot U (2019) Contribution of Malassezia spp. to the development of atopic dermatitis. Mycoses 62(7):588–596PubMedCrossRef Nowicka D, Nawrot U (2019) Contribution of Malassezia spp. to the development of atopic dermatitis. Mycoses 62(7):588–596PubMedCrossRef
25.
go back to reference Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J (2020) An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol 29(5):481–489PubMedCrossRef Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J (2020) An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol 29(5):481–489PubMedCrossRef
26.
go back to reference Mills KJ, Robinson MK, Sherrill JD, Schnell DJ, Xu J (2018) Analysis of gene expression profiles of multiple skin diseases identifies a conserved signature of disrupted homeostasis. Exp Dermatol 27(9):1000–1008PubMedCrossRef Mills KJ, Robinson MK, Sherrill JD, Schnell DJ, Xu J (2018) Analysis of gene expression profiles of multiple skin diseases identifies a conserved signature of disrupted homeostasis. Exp Dermatol 27(9):1000–1008PubMedCrossRef
27.
go back to reference Rigas AS, Skytthe A, Erikstrup C, Rostgaard K, Petersen MS, Hjalgrim H et al (2019) The healthy donor effect impacts self-reported physical and mental health—results from the Danish Blood Donor Study (DBDS). Transfus Med 29(Suppl 1):65–69PubMedCrossRef Rigas AS, Skytthe A, Erikstrup C, Rostgaard K, Petersen MS, Hjalgrim H et al (2019) The healthy donor effect impacts self-reported physical and mental health—results from the Danish Blood Donor Study (DBDS). Transfus Med 29(Suppl 1):65–69PubMedCrossRef
28.
go back to reference Tian C, Hromatka BS, Kiefer AK, Eriksson N, Noble SM, Tung JY et al (2017) Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun 8(1):599PubMedPubMedCentralCrossRef Tian C, Hromatka BS, Kiefer AK, Eriksson N, Noble SM, Tung JY et al (2017) Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun 8(1):599PubMedPubMedCentralCrossRef
29.
go back to reference Mockenhaupt M, Wang CW, Hung SI, Sekula P, Schmidt AH, Pan RY et al (2019) HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans. Allergy 74(11):2227–2230PubMedCrossRef Mockenhaupt M, Wang CW, Hung SI, Sekula P, Schmidt AH, Pan RY et al (2019) HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans. Allergy 74(11):2227–2230PubMedCrossRef
30.
go back to reference Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J et al (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358(6):568–579PubMedCrossRef Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J et al (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358(6):568–579PubMedCrossRef
31.
go back to reference Nicoletti P, Aithal GP, Chamberlain TC, Coulthard S, Alshabeeb M, Grove JI et al (2019) Drug-induced liver injury due to flucloxacillin: relevance of multiple human leukocyte antigen alleles. Clin Pharmacol Ther 106(1):245–253PubMedCrossRef Nicoletti P, Aithal GP, Chamberlain TC, Coulthard S, Alshabeeb M, Grove JI et al (2019) Drug-induced liver injury due to flucloxacillin: relevance of multiple human leukocyte antigen alleles. Clin Pharmacol Ther 106(1):245–253PubMedCrossRef
32.
go back to reference C. Irish Schizophrenia Genomics, C. the Wellcome Trust Case Control (2012) Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry 72(8):620–628CrossRef C. Irish Schizophrenia Genomics, C. the Wellcome Trust Case Control (2012) Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry 72(8):620–628CrossRef
33.
go back to reference Gudjonsson JE, Karason A, Runarsdottir EH, Antonsdottir AA, Hauksson VB, Jonsson HH et al (2006) Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients–an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol 126(4):740–745PubMedCrossRef Gudjonsson JE, Karason A, Runarsdottir EH, Antonsdottir AA, Hauksson VB, Jonsson HH et al (2006) Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients–an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol 126(4):740–745PubMedCrossRef
34.
go back to reference Bettencourt A, Carvalho C, Leal B, Bras S, Lopes D, Martins da Silva A et al (2015) The protective role of HLA-DRB1( *)13 in autoimmune diseases. J Immunol Res 2015:948723PubMedPubMedCentralCrossRef Bettencourt A, Carvalho C, Leal B, Bras S, Lopes D, Martins da Silva A et al (2015) The protective role of HLA-DRB1( *)13 in autoimmune diseases. J Immunol Res 2015:948723PubMedPubMedCentralCrossRef
35.
go back to reference Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H et al (2016) Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis. Sci Rep 6:24767PubMedPubMedCentralCrossRef Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H et al (2016) Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis. Sci Rep 6:24767PubMedPubMedCentralCrossRef
36.
go back to reference Fakiola M, Strange A, Cordell HJ, Miller EN, Pirinen M, Su Z et al (2013) Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet 45(2):208–213PubMedPubMedCentralCrossRef Fakiola M, Strange A, Cordell HJ, Miller EN, Pirinen M, Su Z et al (2013) Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet 45(2):208–213PubMedPubMedCentralCrossRef
37.
go back to reference Singh T, Fakiola M, Oommen J, Singh AP, Singh AK, Smith N et al (2018) Epitope-binding characteristics for risk versus protective DRB1 alleles for visceral leishmaniasis. J Immunol 200(8):2727–2737PubMedCrossRef Singh T, Fakiola M, Oommen J, Singh AP, Singh AK, Smith N et al (2018) Epitope-binding characteristics for risk versus protective DRB1 alleles for visceral leishmaniasis. J Immunol 200(8):2727–2737PubMedCrossRef
38.
go back to reference Zamani M, Modares-Sadegi M, Shirvani F, Zamani H, Emami MH (2014) The involvement of the HLA-DQB1 alleles in the risk and the severity of Iranian coeliac disease patients. Int J Immunogenet 41(4):312–317PubMedCrossRef Zamani M, Modares-Sadegi M, Shirvani F, Zamani H, Emami MH (2014) The involvement of the HLA-DQB1 alleles in the risk and the severity of Iranian coeliac disease patients. Int J Immunogenet 41(4):312–317PubMedCrossRef
39.
go back to reference Tamouza R, Krishnamoorthy R, Giegling I, Leboyer M, Rujescu D (2020) The HLA 8.1 ancestral haplotype in schizophrenia: dual implication in neuro-synaptic pruning and autoimmunity. Acta Psychiatr Scand 141(2):169–171PubMedCrossRef Tamouza R, Krishnamoorthy R, Giegling I, Leboyer M, Rujescu D (2020) The HLA 8.1 ancestral haplotype in schizophrenia: dual implication in neuro-synaptic pruning and autoimmunity. Acta Psychiatr Scand 141(2):169–171PubMedCrossRef
40.
go back to reference Rojas-Villarraga A, Botello-Corzo D, Anaya JM (2010) HLA-Class II in Latin American patients with type 1 diabetes. Autoimmun Rev 9(10):666–673PubMedCrossRef Rojas-Villarraga A, Botello-Corzo D, Anaya JM (2010) HLA-Class II in Latin American patients with type 1 diabetes. Autoimmun Rev 9(10):666–673PubMedCrossRef
42.
go back to reference Nudel R, Benros ME, Krebs MD, Allesoe RL, Lemvigh CK, Bybjerg-Grauholm J et al (2019) Immunity and mental illness: findings from a Danish population-based immunogenetic study of seven psychiatric and neurodevelopmental disorders. Eur J Hum Genet 27(9):1445–1455PubMedPubMedCentralCrossRef Nudel R, Benros ME, Krebs MD, Allesoe RL, Lemvigh CK, Bybjerg-Grauholm J et al (2019) Immunity and mental illness: findings from a Danish population-based immunogenetic study of seven psychiatric and neurodevelopmental disorders. Eur J Hum Genet 27(9):1445–1455PubMedPubMedCentralCrossRef
43.
go back to reference Olivo-Díaz A, Debaz H, Alaez C, Islas VJ, Pérez-Pérez H, Hobart O et al (2004) Role of HLA class II alleles in susceptibility to and protection from localized cutaneous leishmaniasis. Hum Immunol 65(3):255–261PubMedCrossRef Olivo-Díaz A, Debaz H, Alaez C, Islas VJ, Pérez-Pérez H, Hobart O et al (2004) Role of HLA class II alleles in susceptibility to and protection from localized cutaneous leishmaniasis. Hum Immunol 65(3):255–261PubMedCrossRef
44.
go back to reference Kawai M, Suzuki T, Hiruma M, Ikeda S (2014) A retrospective cohort study of tinea pedis and tinea unguium in inpatients in a psychiatric hospital. Med Mycol J 55(2):E35-41PubMedCrossRef Kawai M, Suzuki T, Hiruma M, Ikeda S (2014) A retrospective cohort study of tinea pedis and tinea unguium in inpatients in a psychiatric hospital. Med Mycol J 55(2):E35-41PubMedCrossRef
45.
go back to reference George A, Girisha BS, Rao S (2018) A perspective study of cutaneous manifestations in primary psychiatric disorders in a tertiary care hospital. Indian J Psychiatry 60(2):213–216PubMedPubMedCentralCrossRef George A, Girisha BS, Rao S (2018) A perspective study of cutaneous manifestations in primary psychiatric disorders in a tertiary care hospital. Indian J Psychiatry 60(2):213–216PubMedPubMedCentralCrossRef
Metadata
Title
Human leukocyte antigen system associations in Malassezia-related skin diseases
Authors
P. Lindsø Andersen
G. B. Jemec
C. Erikstrup
M. Didriksen
K. M. Dinh
S. Mikkelsen
E. Sørensen
K. R. Nielsen
M. T. Bruun
H. Hjalgrim
T. F. Hansen
S. G. Sækmose
S. R. Ostrowski
D. M. L. Saunte
O. B. Pedersen
DBDS Genetic Consortium
Publication date
17-11-2022
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 4/2023
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02454-9

Other articles of this Issue 4/2023

Archives of Dermatological Research 4/2023 Go to the issue